AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

SitaOD MSR 100/500 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview SitaOD MSR 100/500 Tablet

Diabetics using the dual-action SitaOD MSR 100/500 Tablet benefit from its blood glucose regulation. This combination medication mitigates severe diabetic complications like renal failure and vision loss, potentially lowering cardiovascular event risk. Prescribed independently or adjunctively with other antidiabetic agents, SitaOD MSR 100/500 Tablet efficacy is enhanced by diet and exercise. Dosage is individualized based on patient health, glucose readings, and concurrent medications. Consuming it with food minimizes gastrointestinal distress. Consistent daily dosing maximizes therapeutic benefit; discontinuation requires medical advisement. Maintaining the prescribed diet and exercise regimen is crucial for optimal diabetes management. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, cephalalgia, and pharyngitis. Concurrent use with insulin or sulfonylureas increases hypoglycemia risk, demanding patient awareness and management strategies. This medication isn't universally suitable. Patients with prior kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption should consult their physician before use. Pregnant or lactating individuals require medical consultation. Inform your doctor of all other medications to avoid interactions. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood sugar levels by your physician is essential throughout treatment.

Primary Ingredients of SitaOD MSR 100/500 Tablet

The provided text is "undefined," which cannot be rephrased. There is no text to rewrite.

Uses of SitaOD MSR 100/500 Tablet

Managing type 2 diabetes

Major Benefits of SitaOD MSR 100/500 Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the SitaOD MSR 100/500 Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should coincide with meals.

Common Side effects of SitaOD MSR 100/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use SitaOD MSR 100/500 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. SitaOD MSR 100/500 Tablets should be administered with a meal.

How SitaOD MSR 100/500 Tablet works:

SitaOD MSR 100/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining SitaOD MSR 100/500 Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of SitaOD MSR 100/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of SitaOD MSR 100/500 Tablet while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose level is outside the normal range. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use SitaOD MSR 100/500 Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is essential. The medication is contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of SitaOD MSR 100/500 Tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take SitaOD MSR 100/500 Tablet :

Should you forget to take a SitaOD MSR 100/500 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About SitaOD MSR 100/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on SitaOD MSR 100/500 Tablet

SitaOD MSR 100/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of SitaOD MSR 100/500 Tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental state. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
SitaOD MSR 100/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
SitaOD MSR 100/500 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD MSR 100/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like SitaOD MSR 100/500) can rarely cause lactic acidosis (MALA), a serious medical emergency involving excessive blood lactic acid. This risk is higher in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
SitaOD MSR 100/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
SitaOD MSR 100/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
SitaOD MSR 100/500 Tablet is contraindicated in patients with allergies to its ingredients or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD MSR 100/500 Tablet with alcohol is unsafe and may raise the risk of lactic acidosis.
Using SitaOD MSR 100/500 Tablets (containing metformin) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of SitaOD MSR 100/500 tablets can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially impacting mental state. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
SitaOD MSR 100/500 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
SitaOD MSR 100/500 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
SitaOD MSR 100/500 Tablet is contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD MSR 100/500 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (SitaOD MSR 100/500 Tablet) can, rarely, cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, older adults, and those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of SitaOD MSR 100/500 tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially affecting mental state. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
SitaOD MSR 100/500 Tablet
107
MRP 124
13% off